Amedisys Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Amedisys ha un patrimonio netto totale di $1.2B e un debito totale di $353.2M, che porta il suo rapporto debito/patrimonio netto a 29.4%. Le sue attività totali e le sue passività totali sono rispettivamente $2.1B e $938.7M. L'EBIT di Amedisys è $208.9M rendendo il suo rapporto di copertura degli interessi 8.1. Ha liquidità e investimenti a breve termine pari a $245.5M.
Informazioni chiave
29.4%
Rapporto debito/patrimonio netto
US$353.21m
Debito
| Indice di copertura degli interessi | 8.1x |
| Contanti | US$245.45m |
| Patrimonio netto | US$1.20b |
| Totale passività | US$938.68m |
| Totale attività | US$2.14b |
Aggiornamenti recenti sulla salute finanziaria
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance
Nov 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $579.9M ) di AMED superano le sue passività a breve termine ( $486.0M ).
Passività a lungo termine: Le attività a breve termine di AMED ( $579.9M ) superano le sue passività a lungo termine ( $452.7M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 9% ) di AMED è considerato soddisfacente.
Riduzione del debito: Il rapporto debito/patrimonio netto di AMED si è ridotto da 39.3% a 29.4% negli ultimi 5 anni.
Copertura del debito: Il debito di AMED è ben coperto dal flusso di cassa operativo ( 59.9% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di AMED sono ben coperti dall'EBIT ( 8.1 x copertura).